P. Burckhardt

AFPL-67. Zoledronic acid safety and efficacy over 5 years in post-menopausal osteoporosis (2007)

Devogelaer, J, Burckhardt, P, Meunier, P, Kaufman, J, Lippuner, K, Body, J, ...

The use of clinical risk factors enhances the perfomance of BMD in the prediction of hip and osteoporotic fractures in men and women. (2007)

Kanis, J.A., Oden, A., Johnell, O., Johansson, H., Laet, C. De, Brown, J., ...

BMD and clinical risk factors predict hip and other osteoporotic fractures. The combination of clinical risk factors and BMD provide higher specificity and sensitivity than either alone. Introduction...

The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women (2007)

Kanis, J.A., Oden, A., Johnell, O., Johansson, H., De Laet, C., Brown, J., ...

SUMMARY: BMD and clinical risk factors predict hip and other osteoporotic fractures. The combination of clinical risk factors and BMD provide higher specificity and sensitivity than either alone....

Bone mineral content in cystic fibrosis patients: correlation with fat-free mass.

Salamoni, F, Roulet, M, Gudinchet, F, Pilet, M, Thiébaud, D, Burckhardt, P

OBJECTIVE: To assess the bone mineral content in well nourished patients with cystic fibrosis and to seek a correlation with fat-free mass. METHODS: Fourteen cystic fibrosis patients aged 6 to 20...